| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Quantum Biopharma Ltd.
13G/A
QNTM · 74764Y205
|
9.8% |
2/3/2026
Event 2/3/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.